HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.

10th Edition of International Conference on Neurology and Brain Disorders

October 21-23, 2024

October 21 -23, 2024 | Baltimore, Maryland, USA
INBC 2022

Elita Delbruck

Speaker at Neurology Conferences -  Elita Delbruck
California University of Science and Medicine,, United States
Title : Rapidly Progressive Sporadic Creutzfeldt-Jakob Disease (CJD): A Case Report and Literature Review

Abstract:

Prion diseases are rare and rapidly progressive neuro-degenerative disorders that are poorly understood. Universally fatal, diagnosis primarily focuses on the excluding other treatable diseases. This case of probable sporadic Creutzfeldt-Jakob Disease (sCJD) in an otherwise healthy 61-year-old male outlines presenting symptoms and disease course. Diagnosis was supported by a positive RTQuIC and detection of 14-3-3 and T-tau proteins in the cerebrospinal fluid. Notable lab findings included oligoclonal bands and elevated natural killer cells. Treatment with corticosteroids, IVIG, levetiracetam, and carbidopa-levodopa were ineffective, while benzodiazepines provided symptomatic relief. This case report and literature review identifies the importance of including sCJD as a differential for patients presenting with rapidly progressive motor and cerebellar dysfunction with constitutional symptoms for early identification of the disease.

What will audience learn from your presentation? 
•    Recognition of the atypical characteristics of an especially rapid clinical course of a patient with CJD for early accurate diagnosis.
•    Diagnostic value of various tools used in aiding diagnosis in this patient such as protein 14-3-3, t-tau protein, RT-QuIC, EEG, and MRI.
•    Novel findings of diagnostic testing in this patient’s cerebrospinal fluid that can potentially aid in understanding the pathophysiology and enhancing diagnostic tools for CJD.
•    Variable efficacy of treatment with levodopa-carbidopa, levetiracetam, corticosteroids, IVIG, and clonazepam in this patient.

 

Biography:

Elita Delbruck studied Cognitive Neuroscience at the University of California, Irvine where she joined the Visual Perception and Neuroimaging Lab in the School of Social Sciences and later also joined the Vawter Lab in the Department of Psychiatry and Human Behavior. She graduated with a Bachelor of Science and several honors awards in 2017. She began medical school at the California University of Science and Medicine in 2019, where she is currently in her last year of pursuing her MD and a residency training program in neurology. She has multiple research publications in neuroscience and aspires to continue her career in clinical neurology research.

Watsapp